New combo therapy targets tough pancreatic cancer
Disease control
Terminated
This study tests a new drug called ABTL0812 added to standard chemotherapy (gemcitabine and nab-paclitaxel) for people with advanced pancreatic cancer that has spread. The goal is to see if the combination is safe and works better than chemo alone. The trial was suspended, so res…
Phase: PHASE1, PHASE2 • Sponsor: Ability Pharmaceuticals SL • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC